Search Tag: Hepatitis C

IMAGING Management

FDA Grants PMA Approval for Hologic's Aptima® Hepatitis C Quant Dx Assay

2017 18 Feb

HCV viral load test now available alongside HIV-1 assay and women's health menu on the fully automated Panther systemHologic, Inc. (Nasdaq: HOLX) has announced that the United States Food and Drug Administration (FDA) has granted PMA approval for the Company's hepatitis C virus (HCV) assay for quantitation of HCV viral load and confirming active HCV... Read more

Lab Management

Beckman Coulter Diagnostics Obtains CE Marks for New HCV RNA & HIV-1 Assays on DxN VERIS MDS

2015 10 Jun

—Beckman Coulter Diagnostics has obtained CE Marking for its DxN VERIS HCV Assay*, a real-time PCR assay for the rapid and reliable quantitative determination of Hepatitis C Virus (HCV) RNA in human plasma, and DxN VERIS HIV-1 Assay*, a real-time PCR assay for the rapid and reliable quantitative measurement of Human Immunodeficiency Virus type 1 (HIV- 1)... Read more

Executive Health Management

Bio-Rad Grants Beckman Coulter Exclusive Distribution Rights for Access HIV and Hepatitis C Assays

2015 21 Apr

HERCULES, CA and BREA, CA--(Marketwired - Apr 20, 2015) - Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B), a global provider of life science research and clinical diagnostic products and Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, today announced that Bio-Rad is extending its agreement with Beckman Coulter... Read more

ICU Management

Combo Therapy Eradicates Hep C in Liver Transplant Patients

2014 10 Nov

Researchers from the Mayo Clinic (Jacksonville, FA, USA) have found that the use of two new oral medications is effective in fighting hepatitis C infection amongst liver transplant patients. Given the clinical importance of the study, results have been presented in a plenary session of the American Association for the Study of Liver Diseases (The Liver... Read more

Pharmacy Management

First Combination Pill Approved For Hepatitis C

2014 14 Oct

The FDA has approved a new antiviral drug to treat chronic hepatitis C virus (HCV) genotype 1 infections. Harvoni from Gilead Sciences is the first combination drug (ledipasvir/sofosbuvir) for the treatment of HCV as well as the first treatment for the disease that does not require administration with interferon and ribavirin. Edward Cox, MD, MPH,... Read more